SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crow with knife community is rallying around the project's recent website update and its multi-chain capabilities, positioning it as a standout in the meme coin sector. Investors are actively discussing its deflationary burn mechanism and potential for growth as they work to expand the project's presence across multiple blockchain networks.

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF (SIL) is drawing intense investor interest as silver prices reach historic highs, fueled by a persistent physical supply-demand deficit and its critical role in AI and green energy technologies. While some traders are capitalizing on the aggressive price action, others in the community remain divided, debating whether this is a sustainable structural breakout or a speculative bubble prone to rapid deleveraging.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

Investors are actively debating the long-term potential of the 4CHAN token, positioning it as a foundational "index fund" of meme culture with significant upside should it capture broader adoption. While some community members remain skeptical of volatility and price action, proponents emphasize the token's cultural roots, low market capitalization, and historical significance as catalysts for a potential major rally.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors react to a polarizing earnings report that featured record bookings and a massive buyback announcement, yet faced heavy downward pressure amid concerns over Uber competition and weak revenue guidance. The community is sharply divided, with some betting on a short squeeze or long-term AV-driven growth, while vocal bears argue the stock's fundamentals remain broken.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently seeing significant community focus driven by its emergence as the primary settlement layer for autonomous AI agents and institutional interest in its role within the DeFi ecosystem. Traders are actively debating the distinction between various digital assets as commodities, while also weighing staking opportunities against the volatility inherent in the broader crypto market.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is currently under pressure as investors react to concerns over potential credit card interest rate caps and regulatory scrutiny regarding transaction fees. Despite the market volatility and ongoing political debates, long-term participants continue to emphasize the company's entrenched global payment network and high profit margins, leading many to view the price dip as a potential entry opportunity.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is currently a focal point of intense market debate as investors weigh a massive $20 billion share buyback and dividend hike against persistent concerns regarding smartphone saturation and potential revenue loss from Apple. The community remains deeply divided, with some highlighting the company's aggressive pivot toward AI, automotive, and data center growth as a long-term discount opportunity, while others point to bearish analyst downgrades and structural risks as reasons for the stock's recent underperformance.

Powell Industries, Inc. engages in the development, design, manufacturing, and provision of services for custom-engineered products and systems. Its products include integrated power control room substation, electrical houses, traditional and arc-resistant distribution switch gear and control gear, medium-voltage circuit breakers, monitoring and control communications systems, motor control centers, and bus duct systems. The company was founded by William E. Powell in 1947 and is headquartered in Houston, TX.

Powell Industries, Inc.

Powell Industries ($POWL) is currently garnering significant attention as investors weigh the company's role in critical electrical infrastructure, data center buildouts, and natural gas expansion against broader concerns surrounding AI energy efficiency and sector-wide volatility. The community is actively debating the stock's resilience, with many pointing to a robust backlog and strong fundamentals while others closely monitor technical patterns and potential impacts of shifting industry narratives on the stock's relative strength.

PBF Energy, Inc. engages in the operation of a petroleum refinery and supplies unbranded transportation fuels, heating oil, petrochemical feed stocks, lubricants, and other petroleum products in the United States. It operates through the Refining and Logistics segments. The Refining segment is involved in refining crude oil and other feed stocks into petroleum products. The Logistics segment includes owning, leasing, operation, development, and acquisition of crude oil and refined petroleum products terminals, pipelines, storage facilities, and logistics assets. The company was founded on March 1, 2008 and is headquartered in Parsippany, NJ.

PBF Energy Inc - Ordinary Shares - Class A

PBF Energy is trending as investors weigh its role as a high-beta beneficiary of global refining margin strength, particularly driven by shifts in heavy-crude supply chains and crack spread volatility. The community remains focused on the company's operational execution at key facilities and its aggressive de-leveraging strategy as a potential catalyst for long-term re-rating.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana is seeing significant market activity driven by aggressive insider accumulation, specifically from CEO Dustin Moskovitz, who has been consistently purchasing large volumes of shares. While the stock faces ongoing pressure from high operating losses and intense competition, the community is closely monitoring these insider buys as a potential signal for a turnaround or a strategic shift, leading to speculation about a possible future acquisition or long-term value play.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Biotech Stocks To Follow Today - March 17th

Vertex Pharmaceuticals, bioAffinity Technologies, Lunai Bioworks, Danaher, Moderna, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Small Caps Surge on Breakouts, Biotech Validation, and “Real-World” Tech Adoption

Momentum is building across small-cap names this week, with a mix of technical breakouts, clinical validation, and commercialization milestones driving a more constructive tone beneath the surface of the market. $LNAI, $BIAF, $IBRX, $KBLB, $UCAR, $LIDR, $JTAI, $FLYX

<ul class="summary-bullets"><li>BioAffinity tested CyPath Lung on a 71-year-old former smoker with multiple lung nodules.</li><li>The non-invasive test confirmed that the lung nodules were likely due to inflammation rather than cancer.</li><li>CyPath Lung test uses advanced testing and artificial intelligence to analyze cells in a patient’s sputum.</li></ul>Shares of BioAffinity Technologies (BIAF) popped nearly 40% on Tuesday, after the biotech company shared a positive update from a new case study evaluating its non-invasive CyPath Lung test in evaluating lung cancer risk.BioAffinity used the CyPath Lung test on a 71-year-old former smoker with multiple lung nodules, a condition that often leads to invasive procedures.“In this case, the patient’s CyPath Lung result was negative, indicating a low likelihood of malignancy, and together both the patient and I were comfortable in waiting for a follow-up CT scan in three months,” said Daya Nadarajah, MD, the patient’s pulmonologist.Follow-up CT scans showed that the suspicious nodules had resolved, confirming they were likely due to inflammation rather than cancer. CyPath Lung test uses advanced testing and artificial intelligence to analyze cells in a patient’s sputum and detect signs that could suggest cancer.<h2 class="st-heading-2">Record CyPath Lung Revenue&nbsp;</h2>On March 13, 2026, BIAF shares closed 98% higher after the company reported an 87% increase in full-year (FY) 2025 revenue from CyPath Lung, with test volumes rising 99%.Its FY25 revenue fell to $6.2 million from $9.4 million in 2024, as it exited unprofitable services to focus on CyPath Lung. Net loss widened to $14.9 million, mainly due to higher clinical development costs, expanded sales efforts, and changes in warrant valuations.&nbsp;The company also raised $16.9 million to support growth. Looking ahead, it expects CyPath Lung unit sales to more than double in 2026, driving higher revenue.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/BIAF">BIAF</a> on Stocktwits has remained ‘extremely bullish’ over the past week, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/BIAF_jpg_6b2f0f777c.webp" alt="BIAF.jpg">One user said that trading in the stock is a “long term play.”<stembedurl>https://stocktwits.com/MicrocapCowboy/message/647734591</stembedurl>Another user expects the stock to breach its $3 resistance.<stembedurl>https://stocktwits.com/brallt/message/647730923</stembedurl>Around 100 million shares changed hands at the time of writing, well above the average of 0.3 million, according to Stocktwits data.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Why Did BIAF Stock Surge 40% Today?

Shares of BioAffinity Technologies (BIAF) popped around 20% in pre-market trading on Tuesday, after the biotech company shared a positive update from a new case study evaluating its non-invasive CyPath Lung test in evaluating lung cancer risk.

Equity

The stock jumped on heavy volume after a positive update tied to its AI-driven lung cancer screening test.

Case Study Highlights How CyPath Lung Helps Patients Avoid Invasive Procedures

bioAffinity Technologies (NASDAQ:BIAF) released a new clinical case study demonstrating how its noninvasive diagnostic test, CyPath Lung, can help physicians make more confident decisions while sparing patients from unnecessary invasive procedures.

New Case Study: bioAffinity Technologies CyPath Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study that...

Best Small Cap Stocks To Add to Your Watchlist - March 15th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, Direxion Daily PLTR Bear 1X Shares, Vale, and AltC Acquisition are the five Small Cap stocks to watch today, according to MarketBeat's...

Promising Biotech Stocks To Add to Your Watchlist - March 15th

Danaher, Vertex Pharmaceuticals, bioAffinity Technologies, Moderna, United Therapeutics, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Promising Small Cap Stocks To Consider - March 14th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, Direxion Daily PLTR Bear 1X Shares, Vale, AltC Acquisition, PAYP, and Direxion Daily AMD Bear 1X Shares are the seven Small Cap stocks to...

Biotech Stocks To Watch Now - March 14th

Danaher, Vertex Pharmaceuticals, and bioAffinity Technologies are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that...

Small Cap Stocks To Follow Today - March 13th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, and Direxion Daily PLTR Bear 1X Shares are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool...

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.70	$5.98	321.48%	BEAT
Q3 '25	-$2.70	-$4.74	-75.56%	MISSED
Q2 '25	-$0.10	-$5.10	-5000.00%	MISSED
Q1 '25	-$0.16	-$0.16	--	EXPECTED
Q4 '24	-$0.14	-$0.19	-35.71%	MISSED

BIAF
BioAffinity Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest BIAF News

BIAFBioAffinity Technologies Inc